Literature DB >> 27059508

The impact of excision of benign nonendometriotic ovarian cysts on ovarian reserve: a systematic review.

Ahmed A Mohamed1, Tarek K Al-Hussaini2, Mohamed M Fathalla2, Tarek T El Shamy1, Ibrahim I Abdelaal2, Saad A Amer3.   

Abstract

BACKGROUND: Benign nonendometriotic ovarian cysts are very common and often require surgical excision. However, there has been a growing concern over the possible damaging effect of this surgery on ovarian reserve.
OBJECTIVE: The aim of this metaanalysis was to investigate the impact of excision of benign nonendometriotic ovarian cysts on ovarian reserve as determined by serum anti-Müllerian hormone level. DATA SOURCES: MEDLINE, Scopus, ScienceDirect, and Embase were searched electronically. STUDY
DESIGN: All prospective and retrospective cohort studies as well as randomized trials that analyzed changes of serum anti-Müllerian hormone concentrations after excision of benign nonendometriotic cysts were eligible. Twenty-five studies were identified, of which 10 were included in this analysis. DATA EXTRACTION: Two reviewers performed the data extraction independently.
RESULTS: A pooled analysis of 367 patients showed a statistically significant decline in serum anti-Müllerian hormone concentration after ovarian cystectomy (weighted mean difference, -1.14 ng/mL; 95% confidence interval, -1.36 to -0.92; I(2) = 43%). Subgroup analysis including studies with a 3-month follow-up, studies using Gen II anti-Müllerian hormone assay and studies using IOT anti-Müllerian hormone assay improved heterogeneity and still showed significant postoperative decline of circulating anti-Müllerian hormone (weighted mean difference, -1.44 [95% confidence interval, -1.71 to -1.1; I(2) = 0%], -0.88 [95% confidence interval, -1.71 to -0.04; I(2) = 0%], and -1.56 [95% confidence interval, -2.44 to -0.69; I(2) = 22%], respectively). Sensitivity analysis including studies with low risk of bias and excluding studies with possible confounding factors still showed a significant decline in circulating anti-Müllerian hormone.
CONCLUSION: Excision of benign nonendometriotic ovarian cyst(s) seems to result in a marked reduction of circulating anti-Müllerian hormone. It remains to be established whether this reflects a real compromise to ovarian reserve. Crown
Copyright © 2016. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  anti-Müllerian hormone; benign ovarian cysts; ovarian cystectomy; ovarian reserve

Mesh:

Year:  2016        PMID: 27059508     DOI: 10.1016/j.ajog.2016.03.045

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Oocyte cryopreservation in two women with borderline ovarian tumor recurrence.

Authors:  Francesca Filippi; Fabio Martinelli; Edgardo Somigliana; Dorella Franchi; Francesco Raspagliesi; Valentina Chiappa
Journal:  J Assist Reprod Genet       Date:  2020-03-04       Impact factor: 3.412

2.  Deliveries following fertility preservation by ovarian tissue cryopreservation without autotransplantation-what should be expected?

Authors:  Daniel Lantsberg; Adel Farhi; Inna Zaslavsky-Paltiel; Barbara G Silverman; Liat Lerner-Geva; Raoul Orvieto
Journal:  J Assist Reprod Genet       Date:  2018-10-29       Impact factor: 3.412

Review 3.  The Effect of Laparoscopic Endometrioma Surgery on Anti-Müllerian Hormone: A Systematic Review of the Literature and Meta-Analysis.

Authors:  José Moreno-Sepulveda; Carolina Romeral; Geraldine Niño; Assumpció Pérez-Benavente
Journal:  JBRA Assist Reprod       Date:  2022-01-17

4.  The Optimal Time of Ovarian Reserve Recovery After Laparoscopic Unilateral Ovarian Non-Endometriotic Cystectomy.

Authors:  Huaping Li; Bin Yan; Yanli Wang; Zhiming Shu; Ping Li; Yahong Liu; Ying Wang; Xiaohong Ni; Zhou Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-24       Impact factor: 5.555

Review 5.  The role of antimullerian hormone in assessing ovarian damage from chemotherapy, radiotherapy and surgery.

Authors:  Queenie Ho Yan Wong; Richard A Anderson
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-12       Impact factor: 3.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.